![]() |
|
GLOSSARY | STOCK ANALYSIS | INSIDER BUYS | PRODUCT REVIEWS | EDUCATION | SEARCH |
Company Name: CuraGen Corporation Business Overview from 10-K filing for CuraGen Corporation: The following Business Section contains forward-looking statements, which involve risks and uncertainties. The registrant’s actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors. See also “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Risk Factors”. BUSINESS Overview We are a genomics-based pharmaceutical development company dedicated to improving the lives of patients by developing novel protein, antibody and small molecule therapeutics in the areas of oncology, inflammatory diseases, and diabetes. We have taken a systematic approach to identifying and validating the most promising therapeutic targets from the human genome. We use internal resources to develop our potential protein therapeutics and have established development alliances with Abgenix, Inc.
For more information for CuraGen Corporation, click on:
|
Content Library News Insider Buys and Activist Buys RESEARCH Stock Search Engine Guide to Financial Sites FAQ Investors Research Portal Glossary Company Overviews Forums | Work with DailyStocks License our Glossary Write for us About us Feedback | Partners & Sponsors InvestingChannel |